Long-term survival of dogs with stage 4 oral malignant melanoma treated with anti-canine PD-1 therapeutic antibody: A follow-up case report.

Igase M, Inanaga S, Tani K, Nakaichi M, Sakai Y, Sakurai M, Kato M, Tsukui T, Mizuno T

Open source

DOI
10.1111/vco.12829
Published
2022 Dec
Container
Veterinary and comparative oncology
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1111/vco.12829,
  title = {Long-term survival of dogs with stage 4 oral malignant melanoma treated with anti-canine PD-1 therapeutic antibody: A follow-up case report.},
  author = {Igase M and Inanaga S and Tani K and Nakaichi M and Sakai Y and Sakurai M and Kato M and Tsukui T and Mizuno T},
  year = {2022},
  journal = {Veterinary and comparative oncology},
  doi = {10.1111/vco.12829},
  url = {https://doi.org/10.1111/vco.12829}
}

RIS

TY  - JOUR
TI  - Long-term survival of dogs with stage 4 oral malignant melanoma treated with anti-canine PD-1 therapeutic antibody: A follow-up case report.
AU  - Igase M
AU  - Inanaga S
AU  - Tani K
AU  - Nakaichi M
AU  - Sakai Y
AU  - Sakurai M
AU  - Kato M
AU  - Tsukui T
AU  - Mizuno T
PY  - 2022
JO  - Veterinary and comparative oncology
DO  - 10.1111/vco.12829
UR  - https://doi.org/10.1111/vco.12829
ER  - 

APA

M, I., S, I., K, T., M, N., Y, S., M, S., M, K., T, T., & T, M. (2022). Long-term survival of dogs with stage 4 oral malignant melanoma treated with anti-canine PD-1 therapeutic antibody: A follow-up case report.. Veterinary and comparative oncology. https://doi.org/10.1111/vco.12829

Source records